Inogen, Inc. INGN recently announced the launch of its Inogen One G5 portable oxygen concentrator. The product is now available for sale through the company’s domestic direct-to-consumer sales channel ...

Inogen, Inc. INGN is well-poised for growth in the coming quarters due to high prospects in the portable oxygen concentrator (POC) space. The optimism, led by solid third-quarter 2025 performance and ...

Inogen Inc. advanced stock charts by Barron's. View INGN historical stock data and compare to other stocks, and exchanges.

Inogen ($INGN) is up almost 10% on news that it received FDA clearance for its latest home oxygen concentrator. Later this year, the company expects to start selling ...

Inogen INGN witnessed strong momentum in the year-to-date period. Shares of the company have surged 127.1% compared with 9.1% growth of the industry. The S&P 500 composite has risen 17.4% during the ...

Long term investing works well, but it doesn't always work for each individual stock. We don't wish catastrophic capital loss on anyone. Imagine if you held Inogen, Inc. (NASDAQ:INGN) for half a ...

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the introduction of ...

Inogen has continued to struggle, with growth in the rental business overshadowed by declines in direct-to-consumer sales, volatility in business-to-business sales, and pricing pressures. Inogen has ...

Inogen, Inc. is a medical technology company, which engages in the development, manufacture, and marketing of portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to ...